Oxidative Stress: Placenta Function and Dysfunction

American Journal of Reproductive Immunology

Volumn 76, Issue 4, 2016, Pages 258-271

  Wu, Fan ^a   Tian, Fu Ju ^a   Lin, Yi ^a   Xu, Wang Ming ^b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Antioxidants; immunoregulation; intrauterine growth restriction; preeclampsia; spontaneous abortion

Indexed keywords

ENDOTHELIAL DYSFUNCTION; HUMAN; IMMUNOREGULATION; INFLAMMATION; INTRAUTERINE GROWTH RETARDATION; METABOLISM; NONHUMAN; OXIDATIVE STRESS; PLACENTA DISORDER; PLACENTA FUNCTION; PREECLAMPSIA; PRIORITY JOURNAL; REVIEW; SPONTANEOUS ABORTION;

EID: 84987849561     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/aji.12454     Document Type: Review

References (140)

1. Duracková Z: Some current insights into oxidative stress. Physiol Res 2010; 59:459–469.
2. Burton GJ, Jauniaux E: Oxidative stress. Best Pract Res Clin Obstet Gynaecol 2011; 25:287–299.
3. Halliwell B, Whiteman M: Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean? Br J Pharmacol 2004; 142:231–255.
4. Krause BJ, Hanson MA, Casanello P: Role of nitric oxide in placental vascular development and function. Placenta 2011; 32:797–805.
5. Beckman JS, Koppenol WH: Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and the ugly. Am J Physiol 1996; 271:C1424–C1437.
6. Marseglia L, D'Angelo G, Manti S, Arrigo T, Barberi I, Reiter RJ, Gitto E: Oxidative stress-mediated aging during the fetal and perinatal periods. Oxid Med Cell Longev 2014; 2014:358375.
7. Burton GJ: Oxygen, the Janus gas; its effects on human placental development and function. J Anat 2009; 215:27–35.
8. Hatfield SM, Kjaergaard J, Lukashev D, Schreiber TH, Belikoff B, Abbott R, Sethumadhavan S, Philbrook P, Ko K, Cannici R, Thayer M, Rodig S, Kutok JL, Jackson EK, Karger B, Podack ER, Ohta A, Sitkovsky MV: Immunological mechanisms of the antitumor effects of supplemental oxygenation. Sci Transl Med 2015; 7:277ra230.
9. Toescu V, Nuttall SL, Martin U, Kendall MJ, Dunne F: Oxidative stress and normal pregnancy. Clin Endocrinol (Oxf) 2002; 57:609–613.
10. Dröse S, Brandt U: Molecular mechanisms of superoxide production by the mitochondrial respiratory chain. Adv Exp Med Biol 2012; 748:145–169.
11. Murphy MP: How mitochondria produce reactive oxygen species. Biochem J 2009; 417:1–13.
12. Balaban RS, Nemoto S, Finkel T: Mitochondria, oxidants, and aging. Cell 2005; 120:483–495.
13. Bhandary B, Marahatta A, Kim HR, Chae HJ: An involvement of oxidative stress in endoplasmic reticulum stress and its associated diseases. Int J Mol Sci 2012; 14:434–456.
14. Kania E, Pająk B, Orzechowski A: Calcium homeostasis and ER stress in control of autophagy in cancer cells. Biomed Res Int 2015; 2015:352794.
15. Kalyanaraman B: Teaching the basics of redox biology to medical and graduate students: oxidants, antioxidants and disease mechanisms. Redox Biol 2013; 1:244–257.
16. Förstermann U: Nitric oxide and oxidative stress in vascular disease. Pflugers Arch 2010; 459:923–939.
17. Magenta A, Greco S, Capogrossi MC, Gaetano C, Martelli F: Nitric oxide, oxidative stress, and p66Shc interplay in diabetic endothelial dysfunction. Biomed Res Int 2014; 2014:193095.
18. Sánchez-Aranguren LC, Prada CE, Riaño-Medina CE, Lopez M: Endothelial dysfunction and preeclampsia: role of oxidative stress. Front Physiol 2014; 5:372.
19. Jiang F, Zhang Y, Dusting GJ: NADPH oxidase-mediated redox signaling: roles in cellular stress response, stress tolerance, and tissue repair. Pharmacol Rev 2011; 63:218–242.
20. Ortiz GG, Pacheco-Moisés FP, Bitzer-Quintero OK, Ramírez-Anguiano AC, Flores-Alvarado LJ, Ramírez-Ramírez V, Macias-Islas MA, Torres-Sánchez ED: Immunology and oxidative stress in multiple sclerosis: clinical and basic approach. Clin Dev Immunol 2013; 2013:708659.
21. Lamarca B: The role of immune activation in contributing to vascular dysfunction and the pathophysiology of hypertension during preeclampsia. Minerva Ginecol 2010; 62:105–120.
22. MacMicking J, Xie QW, Nathan C: Nitric oxide and macrophage function. Annu Rev Immunol 1997; 15:323–350.
23. Gupta AK, Hasler P, Holzgreve W, Hahn S: Neutrophil NETs: a novel contributor to preeclampsia-associated placental hypoxia? Semin Immunopathol 2007; 29:163–167.
24. Rizzo A, Roscino MT, Binetti F, Sciorsci RL: Roles of reactive oxygen species in female reproduction. Reprod Domest Anim 2012; 47:344–352.
25. Watson AL, Skepper JN, Jauniaux E, Burton GJ: Changes in concentration, localization and activity of catalase within the human placenta during early gestation. Placenta 1998; 19:27–34.
26. Jauniaux E, Watson AL, Hempstock J, Bao YP, Skepper JN, Burton GJ: Onset of maternal arterial blood flow and placental oxidative stress. A possible factor in human early pregnancy failure. Am J Pathol 2000; 157:2111–2122.
27. Watson AL, Skepper JN, Jauniaux E, Burton GJ: Susceptibility of human placental syncytiotrophoblastic mitochondria to oxygen-mediated damage in relation to gestational age. J Clin Endocrinol Metab 1998; 83:1697–1705.
28. Boggess KA, Kay HH, Crapo JD, Moore WF, Suliman HB, Oury TD: Differential localization of placental extracellular superoxide dismutase as pregnancy progresses. Am J Obstet Gynecol 2000; 183:199–205.
29. Tarrade A, Lecarpentier E, Gil S, Morel O, Zahr N, Dahirel M, Tsatsaris V, Chavatte-Palmer P: Analysis of placental vascularization in a pharmacological rabbit model of IUGR induced by L-NAME, a nitric oxide synthase inhibitor. Placenta 2014; 35:254–259.
30. Caniggia I, Mostachfi H, Winter J, Gassmann M, Lye SJ, Kuliszewski M, Post M: Hypoxia-inducible factor-1 mediates the biological effects of oxygen on human trophoblast differentiation through TGFbeta(3). J Clin Invest 2000; 105:577–587.
31. Pereira RD, De Long NE, Wang RC, Yazdi FT, Holloway AC, Raha S: Angiogenesis in the placenta: the role of reactive oxygen species signaling. Biomed Res Int 2015; 2015:814543.
32. Kweider N, Huppertz B, Kadyrov M, Rath W, Pufe T, Wruck CJ: A possible protective role of Nrf2 in preeclampsia. Ann Anat 2014; 196:268–277.
33. Rudov A, Balduini W, Carloni S, Perrone S, Buonocore G, Albertini MC: Involvement of miRNAs in placental alterations mediated by oxidative stress. Oxid Med Cell Longev 2014; 2014:103068.
34. Sharma S: Natural killer cells and regulatory T cells in early pregnancy loss. Int J Dev Biol 2014; 58:219–229.
35. Cerdeira AS, Rajakumar A, Royle CM, Lo A, Husain Z, Thadhani RI, Sukhatme VP, Karumanchi SA, Kopcow HD: Conversion of peripheral blood NK cells to a decidual NK-like phenotype by a cocktail of defined factors. J Immunol 2013; 190:3939–3948.
36. Harlin H, Hanson M, Johansson CC, Sakurai D, Poschke I, Norell H, Malmberg KJ, Kiessling R: The CD16- CD56(bright) NK cell subset is resistant to reactive oxygen species produced by activated granulocytes and has higher antioxidative capacity than the CD16+ CD56(dim) subset. J Immunol 2007; 179:4513–4519.
37. Fu B, Li X, Sun R, Tong X, Ling B, Tian Z, Wei H: Natural killer cells promote immune tolerance by regulating inflammatory TH17 cells at the human maternal-fetal interface. Proc Natl Acad Sci USA 2013; 110:E231–E240.
38. Thaxton JE, Sharma S: Interleukin-10: a multi-faceted agent of pregnancy. Am J Reprod Immunol 2010; 63:482–491.
39. Hanna J, Goldman-Wohl D, Hamani Y, Avraham I, Greenfield C, Natanson-Yaron S, Prus D, Cohen-Daniel L, Arnon TI, Manaster I, Gazit R, Yutkin V, Benharroch D, Porgador A, Keshet E, Yagel S, Mandelboim O: Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nat Med 2006; 12:1065–1074.
40. Hu Y, Eastabrook G, Tan R, MacCalman CD, Dutz JP, von Dadelszen P: Decidual NK cell-derived conditioned medium enhances capillary tube and network organization in an extravillous cytotrophoblast cell line. Placenta 2010; 31:213–221.
41. Chen CP, Piao L, Chen X, Yu J, Masch R, Schatz F, Lockwood CJ, Huang SJ: Expression of interferon γ by decidual cells and natural killer cells at the human implantation site: implications for preeclampsia, spontaneous abortion, and intrauterine growth restriction. Reprod Sci 2015; 22:1461–1467.
42. Engert S, Rieger L, Kapp M, Becker JC, Dietl J, Kämmerer U: Profiling chemokines, cytokines and growth factors in human early pregnancy decidua by protein array. Am J Reprod Immunol 2007; 58:129–137.
43. De Oliveira LG, Lash GE, Murray-Dunning C, Bulmer JN, Innes BA, Searle RF, Sass N, Robson SC: Role of interleukin 8 in uterine natural killer cell regulation of extravillous trophoblast cell invasion. Placenta 2010; 31:595–601.
44. Lash GE, Otun HA, Innes BA, Percival K, Searle RF, Robson SC, Bulmer JN: Regulation of extravillous trophoblast invasion by uterine natural killer cells is dependent on gestational age. Hum Reprod 2010; 25:1137–1145.
45. Fraser R, Whitley GS, Johnstone AP, Host AJ, Sebire NJ, Thilaganathan B, Cartwright JE: Impaired decidual natural killer cell regulation of vascular remodelling in early human pregnancies with high uterine artery resistance. J Pathol 2012; 228:322–332.
46. Quenby S, Nik H, Innes B, Lash G, Turner M, Drury J, Bulmer J: Uterine natural killer cells and angiogenesis in recurrent reproductive failure. Hum Reprod 2009; 24:45–54.
47. Hofmann AP, Gerber SA, Croy BA: Uterine natural killer cells pace early development of mouse decidua basalis. Mol Hum Reprod 2014; 20:66–76.
48. Kalkunte SS, Mselle TF, Norris WE, Wira CR, Sentman CL, Sharma S: Vascular endothelial growth factor C facilitates immune tolerance and endovascular activity of human uterine NK cells at the maternal-fetal interface. J Immunol 2009; 182:4085–4092.
49. Riley JK, Yokoyama WM: NK cell tolerance and the maternal-fetal interface. Am J Reprod Immunol 2008; 59:371–387.
50. Le Bouteiller P: HLA-G in human early pregnancy: control of uterine immune cell activation and likely vascular remodeling. Biomed J 2015; 38:32–38.
51. Braud VM, Allan DS, O'Callaghan CA, Söderström K, D'Andrea A, Ogg GS, Lazetic S, Young NT, Bell JI, Phillips JH, Lanier LL, McMichael AJ: HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 1998; 391:795–799.
52. Chazara O, Xiong S, Moffett A: Maternal KIR and fetal HLA-C: a fine balance. J Leukoc Biol 2011; 90:703–716.
53. Peraldi MN, Berrou J, Dulphy N, Seidowsky A, Haas P, Boissel N, Metivier F, Randoux C, Kossari N, Guérin A, Geffroy S, Delavaud G, Marin-Esteban V, Glotz D, Charron D, Toubert A: Oxidative stress mediates a reduced expression of the activating receptor NKG2D in NK cells from end-stage renal disease patients. J Immunol 2009; 182:1696–1705.
54. Kono K, Salazar-Onfray F, Petersson M, Hansson J, Masucci G, Wasserman K, Nakazawa T, Anderson P, Kiessling R: Hydrogen peroxide secreted by tumor-derived macrophages down-modulates signal-transducing zeta molecules and inhibits tumor-specific T cell-and natural killer cell-mediated cytotoxicity. Eur J Immunol 1996; 26:1308–1313.
55. Corsi MM, Maes HH, Wasserman K, Fulgenzi A, Gaja G, Ferrero ME: Protection by L-2-oxothiazolidine-4-carboxylic acid of hydrogen peroxide-induced CD3zeta and CD16zeta chain down-regulation in human peripheral blood lymphocytes and lymphokine-activated killer cells. Biochem Pharmacol 1998; 56:657–662.
56. Gelderman KA, Hultqvist M, Pizzolla A, Zhao M, Nandakumar KS, Mattsson R, Holmdahl R: Macrophages suppress T cell responses and arthritis development in mice by producing reactive oxygen species. J Clin Invest 2007; 117:3020–3028.
57. Hultqvist M, Bäcklund J, Bauer K, Gelderman KA, Holmdahl R: Lack of reactive oxygen species breaks T cell tolerance to collagen type II and allows development of arthritis in mice. J Immunol 2007; 179:1431–1437.
58. Gelderman KA, Hultqvist M, Holmberg J, Olofsson P, Holmdahl R: T cell surface redox levels determine T cell reactivity and arthritis susceptibility. Proc Natl Acad Sci USA 2006; 103:12831–12836.
59. Malmberg KJ, Arulampalam V, Ichihara F, Petersson M, Seki K, Andersson T, Lenkei R, Masucci G, Pettersson S, Kiessling R: Inhibition of activated/memory (CD45RO(+)) T cells by oxidative stress associated with block of NF-kappaB activation. J Immunol 2001; 167:2595–2601.
60. Lahdenpohja N, Savinainen K, Hurme M: Pre-exposure to oxidative stress decreases the nuclear factor-kappa B-dependent transcription in T lymphocytes. J Immunol 1998; 160:1354–1358.
61. Bao SH, Wang XP, De Lin Q, Wang WJ, Yin GJ, Qiu LH: Decidual CD4+CD25+CD127dim/- regulatory T cells in patients with unexplained recurrent spontaneous miscarriage. Eur J Obstet Gynecol Reprod Biol 2011; 155:94–98.
62. Mougiakakos D, Johansson CC, Kiessling R: Naturally occurring regulatory T cells show reduced sensitivity toward oxidative stress-induced cell death. Blood 2009; 113:3542–3545.
63. Kim HR, Lee A, Choi EJ, Hong MP, Kie JH, Lim W, Lee HK, Moon BI, Seoh JY: Reactive oxygen species prevent imiquimod-induced psoriatic dermatitis through enhancing regulatory T cell function. PLoS ONE 2014; 9:e91146.
64. Kraaij MD, Savage ND, van der Kooij SW, Koekkoek K, Wang J, van den Berg JM, Ottenhoff TH, Kuijpers TW, Holmdahl R, van Kooten C, Gelderman KA: Induction of regulatory T cells by macrophages is dependent on production of reactive oxygen species. Proc Natl Acad Sci USA 2010; 107:17686–17691.
65. Efimova O, Szankasi P, Kelley TW: Ncf1 (p47phox) is essential for direct regulatory T cell mediated suppression of CD4+ effector T cells. PLoS ONE 2011; 6:e16013.
66. Kusmartsev S, Nefedova Y, Yoder D, Gabrilovich DI: Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species. J Immunol 2004; 172:989–999.
67. Nagaraj S, Gupta K, Pisarev V, Kinarsky L, Sherman S, Kang L, Herber DL, Schneck J, Gabrilovich DI: Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer. Nat Med 2007; 13:828–835.
68. Bingisser RM, Tilbrook PA, Holt PG, Kees UR: Macrophage-derived nitric oxide regulates T cell activation via reversible disruption of the Jak3/STAT5 signaling pathway. J Immunol 1998; 160:5729–5734.
69. Jarvie E, Hauguel-de-Mouzon S, Nelson SM, Sattar N, Catalano PM, Freeman DJ: Lipotoxicity in obese pregnancy and its potential role in adverse pregnancy outcome and obesity in the offspring. Clin Sci (Lond) 2010; 119:123–129.
70. Basu S, Haghiac M, Surace P, Challier JC, Guerre-Millo M, Singh K, Waters T, Minium J, Presley L, Catalano PM, Hauguel-de Mouzon S: Pregravid obesity associates with increased maternal endotoxemia and metabolic inflammation. Obesity (Silver Spring) 2011; 19:476–482.
71. Challier JC, Basu S, Bintein T, Minium J, Hotmire K, Catalano PM, Hauguel-de Mouzon S: Obesity in pregnancy stimulates macrophage accumulation and inflammation in the placenta. Placenta 2008; 29:274–281.
72. Gupta S, Agarwal A, Banerjee J, Alvarez JG: The role of oxidative stress in spontaneous abortion and recurrent pregnancy loss: a systematic review. Obstet Gynecol Surv 2007; 62:335–347.
73. Hustin J, Schaaps JP: Echographic [corrected] and anatomic studies of the maternotrophoblastic border during the first trimester of pregnancy. Am J Obstet Gynecol 1987; 157:162–168.
74. Hustin J, Jauniaux E, Schaaps JP: Histological study of the materno-embryonic interface in spontaneous abortion. Placenta 1990; 11:477–486.
75. Jaffe R, Woods JR Jr: Color Doppler imaging and in vivo assessment of the anatomy and physiology of the early uteroplacental circulation. Fertil Steril 1993; 60:293–297.
76. Burton GJ, Watson AL, Hempstock J, Skepper JN, Jauniaux E: Uterine glands provide histiotrophic nutrition for the human fetus during the first trimester of pregnancy. J Clin Endocrinol Metab 2002; 87:2954–2959.
77. Jauniaux E, Greenwold N, Hempstock J, Burton GJ: Comparison of ultrasonographic and Doppler mapping of the intervillous circulation in normal and abnormal early pregnancies. Fertil Steril 2003; 79:100–106.
78. Burton GJ, Jauniaux E: Placental oxidative stress: from miscarriage to preeclampsia. J Soc Gynecol Investig 2004; 11:342–352.
79. Jauniaux E, Hempstock J, Greenwold N, Burton GJ: Trophoblastic oxidative stress in relation to temporal and regional differences in maternal placental blood flow in normal and abnormal early pregnancies. Am J Pathol 2003; 162:115–125.
80. Hempstock J, Jauniaux E, Greenwold N, Burton GJ: The contribution of placental oxidative stress to early pregnancy failure. Hum Pathol 2003; 34:1265–1275.
81. Al-Gubory KH, Krawiec A, Grange S, Faure P, Garrel C: Abortion-prone mating influences placental antioxidant status and adversely affects placental and foetal development. Free Radic Res 2014; 48:1505–1513.
82. Ishii T, Miyazawa M, Takanashi Y, Tanigawa M, Yasuda K, Onouchi H, Kawabe N, Mitsushita J, Hartman PS, Ishii N: Genetically induced oxidative stress in mice causes thrombocytosis, splenomegaly and placental angiodysplasia that leads to recurrent abortion. Redox Biol 2014; 2:679–685.
83. Lin Y, Chen Y, Zeng Y, Wang T, Zeng S: Lymphocyte phenotyping and NK cell activity analysis in pregnant NOD/SCID mice. J Reprod Immunol 2005; 68:39–51.
84. Lin Y, Wang H, Wang W, Zeng S, Zhong Y, Li DJ: Prevention of embryo loss in non-obese diabetic mice using adoptive ITGA2(+)ISG20(+) natural killer-cell transfer. Reproduction 2009; 137:943–955.
85. Wang W, Lin Y, Zeng S, Li DJ: Improvement of fertility with adoptive CD25+ natural killer cell transfer in subfertile non-obese diabetic mice. Reprod Biomed Online 2009; 18:95–103.
86. Clifford K, Flanagan AM, Regan L: Endometrial CD56+ natural killer cells in women with recurrent miscarriage: a histomorphometric study. Hum Reprod 1999; 14:2727–2730.
87. Giuliani E, Parkin KL, Lessey BA, Young SL, Fazleabas AT: Characterization of uterine NK cells in women with infertility or recurrent pregnancy loss and associated endometriosis. Am J Reprod Immunol 2014; 72:262–269.
88. Emmer PM, Steegers EA, Kerstens HM, Bulten J, Nelen WL, Boer K, Joosten I: Altered phenotype of HLA-G expressing trophoblast and decidual natural killer cells in pathological pregnancies. Hum Reprod 2002; 17:1072–1080.
89. Wang S, Li YP, Ding B, Zhao YR, Chen ZJ, Xu CY, Fu YB, Wang XT: Recurrent miscarriage is associated with a decline of decidual natural killer cells expressing killer cell immunoglobulin-like receptors specific for human leukocyte antigen C. J Obstet Gynaecol Res 2014; 40:1288–1295.
90. Mei S, Tan J, Chen H, Chen Y, Zhang J: Changes of CD4+CD25high regulatory T cells and FOXP3 expression in unexplained recurrent spontaneous abortion patients. Fertil Steril 2010; 94:2244–2247.
91. Gharesi-Fard B: Preoxiredoxin family members (prx3 and prx4) and pregnancy disorder (recurrent pregnancy loss). Methods Mol Biol 2015; 1208:299–311.
92. Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R: Pre-eclampsia. Lancet 2010; 376:631–644.
93. Beauséjour A, Bibeau K, Lavoie JC, St-Louis J, Brochu M: Placental oxidative stress in a rat model of preeclampsia. Placenta 2007; 28:52–58.
94. Yang X, Guo L, Li H, Chen X, Tong X: Analysis of the original causes of placental oxidative stress in normal pregnancy and pre-eclampsia: a hypothesis. J Matern Fetal Neonatal Med 2012; 25:884–888.
95. Hung TH, Burton GJ: Hypoxia and reoxygenation: a possible mechanism for placental oxidative stress in preeclampsia. Taiwan J Obstet Gynecol 2006; 45:189–200.
96. Hung TH, Skepper JN, Charnock-Jones DS, Burton GJ: Hypoxia-reoxygenation: a potent inducer of apoptotic changes in the human placenta and possible etiological factor in preeclampsia. Circ Res 2002; 90:1274–1281.
97. Ishihara N, Matsuo H, Murakoshi H, Laoag-Fernandez JB, Samoto T, Maruo T: Increased apoptosis in the syncytiotrophoblast in human term placentas complicated by either preeclampsia or intrauterine growth retardation. Am J Obstet Gynecol 2002; 186:158–166.
98. Williams PJ, Bulmer JN, Searle RF, Innes BA, Robson SC: Altered decidual leucocyte populations in the placental bed in pre-eclampsia and foetal growth restriction: a comparison with late normal pregnancy. Reproduction 2009; 138:177–184.
99. Bachmayer N, Rafik Hamad R, Liszka L, Bremme K, Sverremark-Ekström E: Aberrant uterine natural killer (NK)-cell expression and altered placental and serum levels of the NK-cell promoting cytokine interleukin-12 in pre-eclampsia. Am J Reprod Immunol 2006; 56:292–301.
100. Wimalasundera RC, Larbalestier N, Smith JH, de Ruiter A, McG Thom SA, Hughes AD, Poulter N, Regan L, Taylor GP: Pre-eclampsia, antiretroviral therapy, and immune reconstitution. Lancet 2002; 360:1152–1154.
101. Hiby SE, Walker JJ, O'shaughnessy KM, Redman CW, Carrington M, Trowsdale J, Moffett A: Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J Exp Med 2004; 200:957–965.
102. Redman CW, Sargent IL: Immunology of pre-eclampsia. Am J Reprod Immunol 2010; 63:534–543.
103. Myatt L, Webster RP: Vascular biology of preeclampsia. J Thromb Haemost 2009; 7:375–384.
104. Redman CW, Sargent IL: Placental stress and pre-eclampsia: a revised view. Placenta 2009; 30(Suppl A):S38–S42.
105. Redman CW, Sargent IL: Circulating microparticles in normal pregnancy and pre-eclampsia. Placenta 2008; 29(Suppl A):S73–S77.
106. Tannetta DS, Dragovic RA, Gardiner C, Redman CW, Sargent IL: Characterisation of syncytiotrophoblast vesicles in normal pregnancy and pre-eclampsia: expression of Flt-1 and endoglin. PLoS ONE 2013; 8:e56754.
107. Holder BS, Tower CL, Jones CJ, Aplin JD, Abrahams VM: Heightened pro-inflammatory effect of preeclamptic placental microvesicles on peripheral blood immune cells in humans. Biol Reprod 2012; 86:103.
108. Aly AS, Khandelwal M, Zhao J, Mehmet AH, Sammel MD, Parry S: Neutrophils are stimulated by syncytiotrophoblast microvillous membranes to generate superoxide radicals in women with preeclampsia. Am J Obstet Gynecol 2004; 190:252–258.
109. Gupta AK, Rusterholz C, Huppertz B, Malek A, Schneider H, Holzgreve W, Hahn S: A comparative study of the effect of three different syncytiotrophoblast micro-particles preparations on endothelial cells. Placenta 2005; 26:59–66.
110. Stenqvist AC, Nagaeva O, Baranov V, Mincheva-Nilsson L: Exosomes secreted by human placenta carry functional Fas ligand and TRAIL molecules and convey apoptosis in activated immune cells, suggesting exosome-mediated immune privilege of the fetus. J Immunol 2013; 191:5515–5523.
111. Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee JJ, Lötvall JO: Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007; 9:654–659.
112. Eldh M, Ekström K, Valadi H, Sjöstrand M, Olsson B, Jernås M, Lötvall J: Exosomes communicate protective messages during oxidative stress; possible role of exosomal shuttle RNA. PLoS ONE 2010; 5:e15353.
113. Shaker OG, Sadik NA: Pathogenesis of preeclampsia: implications of apoptotic markers and oxidative stress. Hum Exp Toxicol 2013; 32:1170–1178.
114. Zavalza-Gómez AB: Obesity and oxidative stress: a direct link to preeclampsia? Arch Gynecol Obstet 2011; 283:415–422.
115. Abad C, Proverbio T, Piñero S, Botana D, Chiarello DI, Marín R, Proverbio F: Preeclampsia, placenta, oxidative stress, and PMCA. Hypertens Pregnancy 2012; 31:427–441.
116. Guller S: Role of the syncytium in placenta-mediated complications of preeclampsia. Thromb Res 2009; 124:389–392.
117. Shao Y, Cheng Z, Li X, Chernaya V, Wang H, Yang XF: Immunosuppressive/anti-inflammatory cytokines directly and indirectly inhibit endothelial dysfunction–a novel mechanism for maintaining vascular function. J Hematol Oncol 2014; 7:80.
118. Parra-Cordero M, Bosco C, González J, Gutiérrez R, Barja P, Rodrigo R: Immunohistochemical expression of von Willebrand factor in the preeclamptic placenta. J Mol Histol 2011; 42:459–465.
119. Bosco C, González J, Gutiérrez R, Parra-Cordero M, Barja P, Rodrigo R: Oxidative damage to pre-eclamptic placenta: immunohistochemical expression of VEGF, nitrotyrosine residues and von Willebrand factor. J Matern Fetal Neonatal Med 2012; 25:2339–2345.
120. Wang A, Rana S, Karumanchi SA: Preeclampsia: the role of angiogenic factors in its pathogenesis. Physiology (Bethesda) 2009; 24:147–158.
121. Dhillion P, Wallace K, Herse F, Scott J, Wallukat G, Heath J, Mosely J, Martin JN Jr, Dechend R, LaMarca B: IL-17-mediated oxidative stress is an important stimulator of AT1-AA and hypertension during pregnancy. Am J Physiol Regul Integr Comp Physiol 2012; 303:R353–R358.
122. Cornelius DC, Hogg JP, Scott J, Wallace K, Herse F, Moseley J, Wallukat G, Dechend R, LaMarca B: Administration of interleukin-17 soluble receptor C suppresses TH17 cells, oxidative stress, and hypertension in response to placental ischemia during pregnancy. Hypertension 2013; 62:1068–1073.
123. Scifres CM, Nelson DM: Intrauterine growth restriction, human placental development and trophoblast cell death. J Physiol 2009; 587:3453–3458.
124. Mert I, Oruc AS, Yuksel S, Cakar ES, Buyukkagnici U, Karaer A, Danisman N: Role of oxidative stress in preeclampsia and intrauterine growth restriction. J Obstet Gynaecol Res 2012; 38:658–664.
125. Kim YJ, Hong YC, Lee KH, Park HJ, Park EA, Moon HS, Ha EH: Oxidative stress in pregnant women and birth weight reduction. Reprod Toxicol 2005; 19:487–492.
126. Maisonneuve E, Delvin E, Ouellet A, Morin L, Dubé J, Boucoiran I, Moutquin JM, Fouron JC, Klam S, Levy E, Leduc L: Oxidative conditions prevail in severe IUGR with vascular disease and Doppler anomalies. J Matern Fetal Neonatal Med 2014; 15:1–5.
127. Sheppard BL, Bonnar J: An ultrastructural study of utero-placental spiral arteries in hypertensive and normotensive pregnancy and fetal growth retardation. Br J Obstet Gynaecol 1981; 88:695–705.
128. Araújo JR, Correia-Branco A, Pereira AC, Pinho MJ, Keating E, Martel F: Oxidative stress decreases uptake of neutral amino acids in a human placental cell line (BeWo cells). Reprod Toxicol 2013; 40:76–81.
129. Osorio JC, Cruz E, Milanés M, Ramírez Y, Sierra M, Cruz M, Sanfiel L: Influence of maternal redox status on birth weight. Reprod Toxicol 2011; 31:35–40.
130. Olofsson P, Laurini RN, Marsál K: A high uterine artery pulsatility index reflects a defective development of placental bed spiral arteries in pregnancies complicated by hypertension and fetal growth retardation. Eur J Obstet Gynecol Reprod Biol 1993; 49:161–168.
131. Kadyrov M, Kingdom JC, Huppertz B: Divergent trophoblast invasion and apoptosis in placental bed spiral arteries from pregnancies complicated by maternal anemia and early-onset preeclampsia/intrauterine growth restriction. Am J Obstet Gynecol 2006; 194:557–563.
132. Burton GJ, Yung HW, Cindrova-Davies T, Charnock-Jones DS: Placental endoplasmic reticulum stress and oxidative stress in the pathophysiology of unexplained intrauterine growth restriction and early onset preeclampsia. Placenta 2009; 30(Suppl A):S43–S48.
133. Brosens I, Pijnenborg R, Vercruysse L, Romero R: The “Great Obstetrical Syndromes” are associated with disorders of deep placentation. Am J Obstet Gynecol 2011; 204:193–201.
134. Di Renzo GC: The great obstetrical syndromes. J Matern Fetal Neonatal Med 2009; 22:633–635.
135. Takagi Y, Nikaido T, Toki T, Kita N, Kanai M, Ashida T, Ohira S, Konishi I: Levels of oxidative stress and redox-related molecules in the placenta in preeclampsia and fetal growth restriction. Virchows Arch 2004; 444:49–55.
136. Mayhew TM, Ohadike C, Baker PN, Crocker IP, Mitchell C, Ong SS: Stereological investigation of placental morphology in pregnancies complicated by pre-eclampsia with and without intrauterine growth restriction. Placenta 2003; 24:219–226.
137. Biron-Shental T, Sukenik-Halevy R, Sharon Y, Goldberg-Bittman L, Kidron D, Fejgin MD, Amiel A: Short telomeres may play a role in placental dysfunction in preeclampsia and intrauterine growth restriction. Am J Obstet Gynecol 2010; 202:381.e381–381.e387.
138. Chen YH, Xu DX, Zhao L, Wang H, Wang JP, Wei W: Ascorbic acid protects against lipopolysaccharide-induced intra-uterine fetal death and intra-uterine growth retardation in mice. Toxicology 2006; 217:39–45.
139. Salles AM, Galvao TF, Silva MT, Motta LC, Pereira MG: Antioxidants for preventing preeclampsia: a systematic review. ScientificWorldJournal 2012; 2012:243476.
140. Gallo C, Renzi P, Loizzo S, Loizzo A, Piacente S, Festa M, Caputo M, Tecce MF, Capasso A: Potential therapeutic effects of vitamin E and C on placental oxidative stress induced by nicotine: an in vitro evidence. Open Biochem J 2010; 4:77–82.